Medical Director
HOPE Vascular & Podiatry
Houston, Texas
Session Moderator
SESSION 28: NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
Presenter
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
Presenter
SESSION 37: MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE-BASED LABS (OBLS) AND AMBULATORY SURGERY CENTERS (ASCS)
SESSION 28: NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
Presenter
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
Intraoperative Optimization Of DVA (LimFlow) For No Option CLTI: Flow Volume In The Lateral Plantar Vein Is A Crucial Parameter To Measure And Modulate For DVA Success: How To Do It And How To Use It
1:42 PM - 1:47 PM
Presenter
SESSION 37: MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE-BASED LABS (OBLS) AND AMBULATORY SURGERY CENTERS (ASCS)
How To Build An Outpatient Center Of Excellence Committed To The Treatment Of CLTI: When Is An OBL Better And When Is An ASC Better – For Patients, For Surgeons
3:58 PM - 4:03 PM